Navana Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Cash & Equivalents	328.92	440.93	66.43	25.78	54.72
Cash & Short-Term Investments	328.92	440.93	66.43	25.78	54.72
Cash Growth	-30.20%	563.78%	157.71%	-52.89%	-
Accounts Receivable	877.24	788.15	519.97	434.81	360.4
Other Receivables	22.76	13.09	27.85	28.08	75.42
Receivables	900	801.24	547.82	462.89	435.82
Inventory	2,009	1,554	1,170	931.44	826.17
Prepaid Expenses	-	0.95	2.59	1.98	1.86
Other Current Assets	1,949	1,993	1,109	387.04	309.93
Total Current Assets	5,188	4,789	2,895	1,809	1,628
Property, Plant & Equipment	5,076	4,632	4,029	3,389	2,799
Long-Term Investments	112.32	167.62	159.03	-	-
Other Intangible Assets	0.39	0.55	0.77	0.99	-
Long-Term Deferred Tax Assets	-	-	-	-	23.76
Other Long-Term Assets	-	-	-	0	-
Total Assets	10,377	9,590	7,084	5,199	4,451
Accounts Payable	52.65	731.1	42.65	20.43	34.19
Accrued Expenses	359.3	-	245.36	185.09	161.28
Short-Term Debt	4,607	4,066	2,682	1,143	782.7
Current Portion of Long-Term Debt	5.65	18.09	28.13	18.8	71.31
Current Portion of Leases	39.43	34.72	29.25	34.62	24.13
Current Income Taxes Payable	333.83	-	245.11	141.44	161.28
Other Current Liabilities	44.58	5.01	14.02	28.31	8.23
Total Current Liabilities	5,442	4,855	3,287	1,572	1,243
Long-Term Debt	176.51	120.63	171.39	162.98	60.9
Long-Term Leases	80.53	89.6	100.72	131.53	27.58
Long-Term Deferred Tax Liabilities	153.83	152.11	42.36	28.25	17.3
Other Long-Term Liabilities	-	0	-	-0	-
Total Liabilities	5,853	5,217	3,601	1,895	1,349
Common Stock	1,074	1,074	802.3	802.3	0.8
Additional Paid-In Capital	448.17	448.17	-	-	-
Retained Earnings	634.99	443.03	204.24	535.83	1,135
Comprensive Income & Other	2,366	2,407	2,477	1,966	1,966
Shareholders' Equity	4,523	4,372	3,483	3,304	3,102
Total Liabilities & Equity	10,377	9,590	7,084	5,199	4,451
Total Debt	4,909	4,329	3,012	1,491	966.62
Net Cash (Debt)	-4,468	-3,721	-2,786	-1,466	-911.9
Net Cash Per Share	-41.54	-37.42	-34.73	-18.27	-11.37
Filing Date Shares Outstanding	107.42	107.42	80.23	80.23	80.23
Total Common Shares Outstanding	107.42	107.42	80.23	80.23	80.23
Working Capital	-254.5	-65.55	-391.14	237.08	385.38
Book Value Per Share	42.11	40.71	43.41	41.19	38.67
Tangible Book Value	4,523	4,372	3,482	3,303	3,102
Tangible Book Value Per Share	42.11	40.70	43.40	41.17	38.67
Land	-	2,483	2,483	2,483	2,474
Buildings	-	1,142	745.82	231.9	185.08
Machinery	-	985.02	831.81	789.03	539.94
Construction In Progress	762.03	614.67	403.01	159.04	-

Source: S&P Capital IQ. Standard template. Financial Sources.